Points to consider for prioritizing clinical genetic testing services: a European consensus process oriented at accountability for reasonableness

European Journal of Human Genetics

Volumn 23, Issue 6, 2015, Pages 729-735

  Severin, Franziska ^a   Borry, Pascal ^b   Cornel, Martina C ^c   Daniels, Norman ^d   Fellmann, Florence ^e   Victoria Hodgson, Shirley ^f   Howard, Heidi C ^g,h   John, Jürgen ^a   Kääriäinen, Helena ⁱ   Kayserili, Hülya ^j   Kent, Alastair ^k   Koerber, Florian ^a   Kristoffersson, Ulf ^l   Kroese, Mark ^m   Lewis, Celine ⁿ   Marckmann, Georg ^o   Meyer, Peter ^p,q   Pfeufer, Arne ^a   Schmidtke, Jörg ^r   Skirton, Heather ^s   Tranebjærg, Lisbeth ^t,u   Rogowski, Wolf H ^a,v   more..

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^f ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^g UPPSALA UNIVERSITY   (Sweden)

^h Faculté de Médecine Centre Hospitalo universitaire   (France)

ⁱ NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^j ISTANBUL UNIVERSITY   (Turkey)

^k GENETIC ALLIANCE UK   (United Kingdom)

^l LUND UNIVERSITY   (Sweden)

^m PHG FOUNDATION   (United Kingdom)

ⁿ GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^o UNIVERSITY OF MUNICH   (Germany)

^p Practice of Human Genetics   (Germany)

^q ROSTOCK UNIVERSITY MEDICAL CENTER   (Germany)

^r HANNOVER MEDICAL SCHOOL   (Germany)

^s UNIVERSITY OF PLYMOUTH   (United Kingdom)

^t BISPEBJERG HOSPITAL   (Denmark)

^u UNIVERSITY OF COPENHAGEN   (Denmark)

^v LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALGORITHM; ARTICLE; CLINICAL GENETICS; CONSENSUS; CONTROLLED STUDY; DECISION MAKING; DISEASE COURSE; DISEASE SEVERITY; EUROPEAN; GENETIC COUNSELING; GENETIC SCREENING; GENETIC SERVICE; HEALTH CARE COST; HEALTH CARE PERSONNEL; HUMAN; INFORMATION; MASS MEDIUM; MASS SCREENING; PATIENT CARE; PRIORITY JOURNAL; TASK PERFORMANCE; WORKSHOP; CLINICAL LABORATORY SERVICE; ETHICS; EUROPE; LEGISLATION AND JURISPRUDENCE; SOCIAL BEHAVIOR; STANDARDS;

CLINICAL LABORATORY SERVICES; CONSENSUS; EUROPE; GENETIC TESTING; SOCIAL RESPONSIBILITY;

EID: 84929282608     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/ejhg.2014.190     Document Type: Article

References (28)

1. Rogowski WH, Grosse SD, John J et al: Points to consider in assessing and appraising predictive genetic tests. J Community Genet 2010; 1: 185-194.
2. Grosse SD, Wordsworth S, Payne K: Economic methods for valuing the outcomes of genetic testing: beyond cost-effectiveness analysis. Genet Med 2008; 10: 648-654.
3. Schmidtke J, Pabst B, Nippert I: DNA-based genetic testing is rising steeply in a national health care system with open access to services: A survey of genetic test use in Germany, 1996-2002. Genet Test 2005; 9: 80-84.
4. Javaher P, Kaariainen H, Kristoffersson U et al: EuroGentest: DNA-based testing for heritable disorders in Europe. Community Genet 2008; 11: 75-120.
5. Spending on genetic tests grows: report calls for more genetics education and counselors. Am J Med Genet A 2012; 158A: ix.
6. Assasi N, Schwartz L, Tarride JE, Goeree R, Xie F: Economic evaluations conducted for assessment of genetic testing technologies: A systematic review. Genet Test Mol Bioma 2012; 16: 1322-1335.
7. Rogowski W: Genetic screening by DNA technology. A systematic review of health economic evidence. Int J Technol Assess Health Care 2006; 22: 327-337.
8. Carlson JJ, Henrikson NB, Veenstra DL, Ramsey SD: Economic analyses of human genetics services: A systematic review. Genet Med 2005; 7: 519-523.
9. Rogowski W: Current impact of gene technology on healthcare. A map of economic assessments. Health Policy 2007; 80: 340-357.
10. Mardis ER: The $1000 genome, the $100 000 analysis? Genome Med 2010; 2: 84.
11. Adair A, Hyde-Lay R, Einsiedel E, Caulfield T: Technology assessment and resource allocation for predictive genetic testing: A study of the perspectives of Canadian genetic health care providers. BMC Med Ethics 2009; 10: 6.
12. Rogowski WH, Hartz SC, John JH: Clearing up the hazy road from bench to bedside: A framework for integrating the fourth hurdle into translational medicine. BMC Health Serv Res 2008; 8: 194.
13. Rogowski WH, Grosse SD, Khoury MJ: Challenges of translating genetic tests into clinical and public health practice. Nat Rev Genet 2009; 10: 489-495.
14. Rogowski WH, Grosse SD, Schmidtke J, Marckmann G: Criteria for fairly allocating scarce health-care resources to genetic tests: which matter most? Eur J Hum Genet 2014; 22: 25-31.
15. Severin F, Schmidtke J, Muhlbacher A, Rogowski WH: Eliciting preferences for priority setting in genetic testing: A pilot study comparing best-worst scaling and discretechoice experiments. Eur J Hum Genet 2013; 21: 1202-1208.
16. Daniels N: Just health: meeting health needs fairly. Cambridge [u.a.]: Cambridge University Press, 2008.
17. Daniels N, Sabin J: The ethics of accountability in managed care reform. Health Aff (Millwood) 1998; 17: 50-64.
18. Severin F, Hess W, Schmidtke J, Muhlbacher A, Rogowski W: Value judgments for priority setting criteria in genetic testing: A discrete choice experiment. Health Policy 2014.
19. Becker F, van El CG, Ibarreta D et al: Genetic testing and common disorders in a public health framework: how to assess relevance and possibilities. Background document to the ESHG recommendations on genetic testing and common disorders. Eur J Hum Genet 2011; 19(Suppl 1): S6-S44.
20. McAllister M, Payne K, Macleod R, Nicholls S, Dian D, Davies L: Patient empowerment in clinical genetics services. J Health Psychol 2008; 13: 895-905.
21. Burn J, Gerdes AM, Macrae F et al: Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: An analysis from the CAPP2 randomised controlled trial. Lancet 2011; 378: 2081-2087.
22. Palomaki GE, McClain MR, Melillo S, Hampel HL, Thibodeau SN: EGAPP supplementary evidence review: DNA testing strategies aimed at reducing morbidity and mortality from Lynch syndrome. Genet Med 2009; 11: 42-65.
23. Adank MA, Verhoef S, Oldenburg RA et al: Excess breast cancer risk in first degree relatives of CHEK2 1100delC positive familial breast cancer cases. Eur J Cancer 2013; 49: 1993-1999.
24. Cholongitas E, Germani G, Burroughs AK: Prioritization for liver transplantation. Nature Rev Gastroenterol Hepatol 2010; 7: 659-668.
25. NordE, DanielsN, KamletM: QALYs: some challenges. Value Health 2009; 12(Suppl 1): S10-S15.
26. Hatz MH, Schremser K, Rogowski WH: Is individualized medicine more cost-effective? A systematic review. Pharmacoeconomics 2014; 32: 443-455.
27. Stolk EA, Pickee SJ, Ament AH, Busschbach JJ: Equity in health care prioritisation: An empirical inquiry into social value. Health Policy 2005; 74: 343-355.
28. Fischer KE, Stollenwerk B, Rogowski WH: Link between process and appraisal in coverage decisions: An analysis with structural equation modeling. Med Decis Making 2013; 33: 1009-1025.